Post-exposure prophylaxis for Blood-Borne Viral (BBV) Infections

Area of Science:

• Infectious Diseases
• Public Health
• Virology

Background:

• Blood-borne viral infections like HIV, HBV, and HCV pose significant risks in healthcare settings.
• Transmission occurs through sexual contact or blood-borne contamination, raising concerns for healthcare workers.
• Post-exposure management strategies are critical for preventing infection following exposure.

Purpose of the Study:

• To detail practical management steps for sexual and occupational exposure to HIV, HBV, and HCV.
• To emphasize strategies for preventing viral infections after exposure.
• To highlight the importance of established protocols in healthcare facilities for timely intervention.

Main Methods:

• Review of current guidelines and practices for post-exposure prophylaxis (PEP) for HIV, HBV, and HCV.
• Risk assessment protocols for determining appropriate interventions based on exposure type and source.
• Discussion of pharmacological interventions, including triple Anti-Retroviral Therapy (ART) for HIV and immunizations for HBV.

Main Results:

• Post-exposure management of HIV involves ART, with specific considerations for pregnant individuals and newborns.
• Hepatitis B exposure management depends on risk assessment, potentially requiring Hepatitis B immunoglobulin or vaccination.
• Hepatitis C post-exposure treatment is controversial due to cost and emerging curative therapies, with follow-up and treatment upon seroconversion being an option.

Conclusions:

• Healthcare facilities must implement robust protocols for managing exposures to blood-borne viruses.
• Early initiation of indicated medications, such as ART for HIV, is vital.
• Risk-based assessment and tailored interventions are key to preventing transmission of HIV, HBV, and HCV.